Inhibition of telomerase activity by HDV ribozyme in cancers

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Lu, Yingying ^a   Gu, Junchao ^a   Jin, Dachuan ^b   Gao, Yanjing ^b   Yuan, Mengbiao ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; TELOMERASE; RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; COLON CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; COLON TUMOR; CONFORMATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HEPATITIS DELTA VIRUS; LIVER CELL; LIVER TUMOR; METABOLISM; PATHOLOGY; SYNTHESIS; TUMOR CELL CULTURE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; COLONIC NEOPLASMS; HEPATITIS DELTA VIRUS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NUCLEIC ACID CONFORMATION; RNA; RNA, CATALYTIC; TELOMERASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 78650890426     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-1     Document Type: Article

References (34)

1. Creation of human tumour cells with defined genetic elements. WC Hahn CM Counter AS Lundberg RL Beijersbergen MW Brooks RA Weinberg, Nature 1999 400 464 68 10.1038/22780 10440377
2. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. E Gonzlez-Surez E Samper A Ramírez JM Flores J Martín-Caballero JL Jorcano MA Blasco, EMBO J 2001 20 2619 30 11387197
3. Specific association of human telomerase activity with immortal cells and cancer. NW Kim MA Piatyszek KR Prowse CB Harley MD West PL Ho GM Coviello WE Wright SL Weinrich JW Shay, Science 1994 266 5193 2011 5 10.1126/science.7605428 7605428
4. The RNA component of human telomerase. J Feng WD Funk SS Wang SL Weinrich AA Avilion CP Chiu RR Adams E Chang RC Allsopp J Yu,, et al. Science 1995 269 1236 41 10.1126/science.7544491 7544491
5. A telomerase component is defective in the human disease dyskeratosis congenita. JR Mitchell E Wood K Collins, Nature 1999 402 6761 551 5 10.1038/990141 10591218
6. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells. M Yeo SY Rha HC Jeung SX Hu SH Yang YS Kim SW An HC Chung, Int J Cancer 2005 114 3 484 9 10.1002/ijc.20720 15551309
7. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. M Nosrati S Li S Bagheri D Ginzinger EH Blackburn RJ Debs M Kashani-Sabet, Clin Cancer Res 2004 10 15 4983 90 10.1158/1078-0432.CCR-04-0134 15297398
8. Structure of the human telomerase RNA pseudoknot reveals conserved tertiary interactions essential for function. CA Theimer CA Blois J Feigon, Mol Cell 2005 17 5 671 82 10.1016/j.molcel.2005.01.017 15749017
9. Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5' substrate sequence. S Jeong J Sefcikova RA Tinsley D Rueda NG Walter, Biochemistry 2003 42 25 7727 40 10.1021/bi034627g 12820882
10. Delta ribozyme has the ability to cleave in trans mRNA. GA Roy JP Perealt, Nucleic Acids Res 1999 27 4 924 48 10.1093/nar/27.4.942 (Pubitemid 29209494)
11. Catalytic core structure of the trans-acting HDV ribozyme is subtly influenced by sequence variation outside the core. ME Gondert RA Tinsley D Rueda NG Walter, Biochemistry 2006 45 24 7563 73 10.1021/bi052116j 16768452
12. Detailed analysis of stem I and its 5' and 3' neighbor regions in the trans-acting HDV ribozyme. F Nishikawa M Roy H Fauzi S Nishikawa, Nucleic Acids Res 1999 27 2 403 10 10.1093/nar/27.2.403 9862958
13. Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5' substrate sequence. S Jeong J Sefcikova RA Tinsley D Rueda NG Walter, Biochemistry 2003 42 25 7727 40 10.1021/bi034627g 12820882
14. Analysis of the cleavage reaction of a trans - acting human hepatitis delta virus ribozyme [J]. H Fauzi J Kawakami F Nishikawa,, et al. Nucleic Acids Res 1997 25 15 3124 30 10.1093/nar/25.15.3124 9224614
15. Design and properties of trans-acting HDV ribozymes with extended substrate recognition regions. T Hori F Guo Y Tanaka S Uesugi, Nucleic Acids Res Suppl 2001 1 201 2 12836334
16. Detailed analysis of base preferences at the cleavage site of a transacting HDV ribozyme: a mutation that changes cleavage site specificity. F Nishikawa H Fauzi S Nishikawa, Nucleic Acids Res 1997 25 8 1605 10 10.1093/nar/25.8.1605 9092669
17. Telomerase inhibition, oligonucleotides, and clinical trials. DR Corey, Oncogene 2002 21 4 631 7 10. Bisoffi M, Chakerian AE, Fore ML, Bryant JE, Hernandez JP, Moyzis RK, Griffith JK. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA, Eur. J. Cancer. 1998, 34(8): 1242-9 10.1038/sj.onc.1205063 11850789
18. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. K Naka H Yokozaki W Yasui H Tahara E Tahara E Tahara, Biochem Biophys Res Commun 1999 255 753 58 10.1006/bbrc.1998.9938 10049783
19. A physical and functional constituent of telomerase anchor site. NF Lue, J Biol Chem 2005 280 28 26586 91 10.1074/jbc.M503028200 15905172
20. A conserved secondary structure for telomerase RNA. DP Romero EH Blackburn, Cell 1991 67 2 343 53 10.1016/0092-8674(91)90186-3 1840508
21. Functional reconstitution of wild-type and mutant Tetrahymena telomerase. C Autexier CW Greider, Genes Dev 1994 8 5 563 75 10.1101/gad.8.5.563 7523243
22. Analysis of the cleavage reaction of a trans-acting human hepatitis delta virus ribozyme. H Fauzi J Kawakami F Nishikawa S Nishikawa, Nucleic Acids Res 1997 25 15 3124 30 10.1093/nar/25.15.3124 9224614
23. Substrate specificity of delta ribozyme cleavage. A Sirinart JP Perreault, J Biol Chem 1998 273 21 13182 88 10.1074/jbc.273.21.13182 9582360
24. Cell cycle-regulated trafficking of human telomerase to telomeres. RL Tomlinson TD Ziegler T Supakorndej RM Terns MP Terns, Mol Biol Cell 2006 17 2 955 65 10.1091/mbc.E05-09-0903 16339074
25. Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component SCIENCE IN CHINA (Series C). LIU Bailin QU Yi LIU Shuqiu Ouyang Xuesong, 2002 45 1 87 95 18763067
26. Telomerase is elevated in early S phase in hamster cells, Biochem. PA Kruk DK Orren VA Bohr, Biophys Res Commun 1997 233 712 22
27. Mammalian telomeres end in a large duplex loop. JD Griffith L Comeau S Rosenfield RM Stansel A Biachi H Moss T deLange, Cell 1999 97 503 514 10.1016/S0092-8674(00)80760-6 10338214
28. Telomerase prevents the accelerated cell aging of Werner syndrome fibroblasts. Fiona S Wyllie Christopher J Jones Julia W Skinner Michele F Haughton Corrin Wallis David Wynford-Thomas Richard GA Faragher David Kipling, Nat Genet 2000 24 16 17 10.1038/71630 10615119
29. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblast. JG Ren HL Xia YM Tian T Just GP Cai YR Dai, FEBS Lett 2001 488 133 38 10.1016/S0014-5793(00)02397-8 11163759
30. Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells. Xiuyun Jiang Casey Wilford Stephan Duensing Karl Munger Grace Jones Davy Jones, J Cell Biochem 2001 83 342 354 10.1002/jcb.1228 11573250
31. A novel anti - apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small - cell lung cancers. Mariano Monzá Rafael Rosell Enriqueta Felip Julio Astudillo José Javier nchez José Maestre Cristina Martín Albert Font Agustí Barnadas Albert Abad, J Clin Oncol 1997 17 2100 2104
32. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. H Zhu W Fu MP Mattson, J Neurochem 2000 75 117 124 10.1046/j.1471-4159.2000.0750117.x 10854254
33. Resistance to apoptosis in human cells conferred by telomerase function and telomerase stability. SE Holt VV Glinsky AB Ivanova GV Glinsky, Mol Carcinog 1999 25 241 48 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2- 9 10449030
34. The prognostic molecular markers in heptocellular carcinoma. LX Qin ZY Tang, World J Gastroenterol 2002 8 3 385 92 12046056